Video Experimental Relacionado
Updated: Jul 8, 2026
09:01
Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
Células que inician y propagan el cáncer en la leucemia infantil asociada a TEL-AML1
Dengli Hong1, Rajeev Gupta, Philip Ancliff
1Medical Research Council (MRC) Molecular Haematology Unit, Weatherall Institute for Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DS, UK.
Science (New York, N.Y.)
|January 19, 2008
Resumen
Este estudio identifica las células que propagan el cáncer en la leucemia infantil. El gen de fusión TEL-AML1 actúa como una mutación de primer golpe, alterando la auto-renovación celular y la supervivencia.
Área de la Ciencia:
- Hematología Hematología.
- Biología del cáncer Biología del cáncer.
- Genética La genética.
Sus antecedentes:
- La patogénesis del cáncer implica mutaciones genéticas y el contexto celular.
- La leucemia linfoblástica aguda de células B precursoras de la infancia (B-ALL) es impulsada por alteraciones genéticas específicas.
- Comprender los orígenes celulares y la evolución de la leucemia es crucial.
Objetivo del estudio:
- Para explorar la evolución clonal de la B-ALL TEL-AML1 positiva a la fusión.
- Para identificar y caracterizar las células que propagan el cáncer en la leucemia pediátrica.
- Para establecer la relación entre las células preleucémicas y las células que propagan la leucemia.
Principales métodos:
- Trasplante de compartimentos celulares identificados en ratones inmunocomprometidos.
- Análisis de un par de gemelos monocoriónicos con diferentes estados de leucemia (preleucemia frente a leucemia franca).
- Análisis in vitro de células de la sangre del cordón umbilical diseñadas para expresar el gen de fusión TEL-AML1.
Principales resultados:
- Se identificó un compartimiento celular específico capaz de propagar la leucemia en ratones.
- Se estableció una relación lineal entre las células preleucémicas y las células que propagan la leucemia.
- Se demostró que el gen de fusión TEL-AML1 confería propiedades alteradas de autorrenovación y supervivencia a las células preleucémicas.
Conclusiones:
- El gen de fusión TEL-AML1 funciona como una mutación iniciadora en B-ALL.
- Las células preleucémicas con la fusión TEL-AML1 poseen potencial de propagación del cáncer.
- Esta investigación aclara aspectos clave de la evolución clonal y la patogénesis de la leucemia infantil.
Más Videos Relacionados
Videos de Conceptos Relacionados
02:40Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
02:40Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:15Replicative Cell Senescence
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...